Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Phase 1 Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients with Retinal Disease due to MERTK Mutations	PSCDR	Completed	rAAV2-VMD2-hMERTK	1	rAAV2-VMD2-hMERTK	King Faisal Specialist Hospital and Research Center (Riyadh), King Khaled Eye Specialist Hospital (Riyadh)
A Compartive Multicenter Study of Neoadjuvant Docetaxel/Cisplatin Followed by Concurrent Cisplatin with Radiotherapy using Intensity-Modulated Radition Therapy (IMRT) with or without Bevacizumab for Locally Advanced Nasopharyngeal Cancer	King Fahad Medical City	Terminated	Docetaxel/Cisplatin and Bevacizumab	3	Version 1.3 date 6 may 2012	King Fahad Medical City (Riyadh), Prince Sultan Military Medical City (Riyadh)
"An open-label extension study of the long-term safety,tolerability and efficacy of Ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension(CTEPH)."	GSK	Terminated	Ambrisentan	3	116457	King Fahad Medical City (Riyadh)
Efficacy of lntra-cervical Misoprostol in the Management of Early Pregnancy Failure: Randumized Clinical Trial	King Abdulaziz University Hospital	Rejected	Misoprostol	2	227-15	King Abdulaziz University Hospital (Jeddah)
"A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus"	MSD	Terminated	MK-0431A (Sitagliptin / Metformin) vs Liraglutide	3	MK-0431A-180-00	King Khalid University Hospital (Riyadh)
"Randomized, Open Label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients"	Astellas	Completed	• Micafungin• Fluconazole• Liposomal Amphotericin B• Caspofungin	3b	9463EC0001	King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease.	Eli Lilly	Terminated	Prasugrel	3	H7T-MC-TADO	King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh)
An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients	Alcon	Completed	Travoprost 0.004%	1	C-12-009	King Khaled Eye Specialist Hospital (Riyadh)
A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART)	Merck Serono	Terminated	Lutropin alfa	3b	EMR200061_506	King Abdulaziz University Hospital (Jeddah)
SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety	SPIMACO	Terminated	Fastulin R / Normulin N	3	(version 1.4) Aug 2011	King Fahad Medical City (Riyadh)